Post by BD

Over the past decade, the landscape of subcutaneous (SC) drug delivery of biologics has shifted significantly. The rapidly growing pipeline for these drugs is now characterised by increasingly complex and sensitive formulations, rising viscosities, larger fill volumes and expanding therapeutic applications. These trends have steadily pushed the limits of traditional primary containers and delivery devices. This article discusses the established injection platforms built to achieve reliable and efficient SC delivery, going further to examine new injectable devices in development.These technology bricks address some of the most pressing challenges facing biologic developers today, including drug-container compatibility, high-mass drug formulations and operational flexibility at commercial scale. Read the full ONdrugDelivery article on the BD website. https://bit.ly/4xiDQNi #SubcutaneousDelivery #Biologics #PrefillableSyringes #DrugDelivery